本页面由Tiger Trade Technology Pte. Ltd.提供服务

Anixa Biosciences

2.69
+0.10003.86%
盘后2.690.00000.00%19:17 EDT
成交量:10.68万
成交额:28.16万
市值:8,978.33万
市盈率:-8.54
高:2.69
开:2.65
低:2.56
收:2.59
52周最高:5.46
52周最低:2.33
股本:3,337.67万
流通股本:3,046.27万
量比:1.00
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-0.3151
每股收益(LYR):-0.3367
净资产收益率:-68.07%
总资产收益率:-40.39%
市净率:5.95
市盈率(LYR):-7.99

数据加载中...

2022/01/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/01/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

超过5%披露

Anixa Biosciences Inc
2021/09/01

季度报告

Anixa Biosciences Inc
2021/07/28

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/16

重要事件披露

8-K - Current report
2021/06/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/27

重要事件披露

8-K - Current report
2021/04/02

重要事件披露

8-K - Current report
2021/03/24

重要事件披露

8-K - Current report
2021/03/23

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/22

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/03/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/28

重要事件披露

8-K - Current report